Bernard Chevallier - Concepedia

Author

Bernard Chevallier

Institut Curie

Also Known As

Bernard Chevallier

Publications

730

Citations

H-Index

Concepts

All Affiliations

Institut Curie Institut Claudius Regaud

About

Bernard Chevallier is an author at Institut Curie specializing in radiation oncology, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	353
2	Health Sciences	1	1	241
3	Biostatistics	1	1	89
4	Endocrinology	1	1	89
5	Obstetrics	1	1	89

Bernard Chevallier

Publications

642

Citations

H-Index

Page 1

	Year	Citations
Inflammatory Breast Cancer Bernard Chevallier, Henri Roché, Jean Pierre Olivier, American Journal of Clinical Oncology Surgical OncologyBreast OncologyPathologyMetronomic ChemotherapyGynecology Oncology	1993	241
Prognostic value of estrogen and progesterone receptors in operable breast cancer: Results of a univariate and multivariate analysis Bernard Chevallier, François Heintzmann, Véronique Mosseri, Cancer Surgical OncologyBreast OncologyEstrogen ReceptorGynecologyPathology	1988	89
Serum hyaluronan (hyaluronic acid) in breast cancer patients Bertrand Delpech, Bernard Chevallier, Nadine Reinhardt, International Journal of Cancer	1990	79
Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis Bernard Chevallier, Bernard Asselain, A Kunlin, Cancer	1987	75
Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix Catherine Lhommé, P. Fumoleau, P. Fargeot, Journal of Clinical Oncology	1999	60
Inflammatory breast cancer outcome with epirubicin‐based induction and maintenance chemotherapy Corinne Veyret, Christelle Lévy, P. Chollet, Cancer	2006	42
Docetaxel: a new active agent in the therapy of metastatic breast cancer P. Fumoleau, Andrew D. Seidman, Maureen Trudeau, Expert Opinion on Investigational Drugs	1997	23
A Clinical Screening Cooperative Group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer M. Degardin, Jean Pierre Armand, Bernard Chevallier, Investigational New Drugs Advanced HeadNeck CancerMedicineCancer ManagementPathology	1995	23
Phase I-II Trial of Intensification of the MAID Regimen With Support of Lenograstim (rHuG-CSF) in Patients With Advanced Soft-Tissue Sarcoma (STS) Christine Chevreau, Binh Bui, Bernard Chevallier, American Journal of Clinical Oncology	1999	10

Page 1